1h Free Analyst Time
The continuoglucose monitoring market is forecast to grow by $2588.61 mn during 2022-2027, accelerating at a CAGR of 6.37% during the forecast period. The report on the continuoglucose monitoring market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rise in the diabetic population, technological innovations and advances, and the availability of reimbursement for BGM devices.
The continuoglucose monitoring market is segmented as below:
By Component
- Sensors
- Transmitters
- Receivers
By End-user
- Home care
- Hospitals
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the continuoglucose monitoring market covers the following areas:
- Continuoglucose monitoring market sizing
- Continuoglucose monitoring market forecast
- Continuoglucose monitoring market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Component
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global continuoglucose monitoring market: A. Menarini Industrie Farmaceutiche Riunite Srl, Abbott Laboratories, Ascensia Diabetes Care Holdings AG, B. Braun SE, Dexcom Inc., F. Hoffmann La Roche Ltd., General Electric Co., GlySens Inc., Johnson and Johnson, LifeScan IP Holdings LLC, Medtronic Plc, Medtrum Technologies Inc., Novo Nordisk AS, NXP Semiconductors NV, Senseonics Holdings Inc., STMicroelectronics NV, Tandem Diabetes Care Inc., Terumo Corp., and Ypsomed AG.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is increasing adoption of home healthcare devices.`
According to the report, one of the major drivers for this market is the rise in diabetic population.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- A. Menarini Industrie Farmaceutiche Riunite Srl
- Abbott Laboratories
- Ascensia Diabetes Care Holdings AG
- B. Braun SE
- Dexcom Inc.
- F. Hoffmann La Roche Ltd.
- General Electric Co.
- GlySens Inc.
- Johnson and Johnson
- LifeScan IP Holdings LLC
- Medtronic Plc
- Medtrum Technologies Inc.
- Novo Nordisk AS
- NXP Semiconductors NV
- Senseonics Holdings Inc.
- STMicroelectronics NV
- Tandem Diabetes Care Inc.
- Terumo Corp.
- Ypsomed AG
